Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 19, 2019 Filed Aug 21, 2019 10:07 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,119 | $6.70 | $14,188.82 |
DisclosureSEC source: 0001393726-19-000146 · wf-form4_156639641330396.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,999,872 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.67 to $6.71, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 11:40 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 5,932 | $6.56 | $38,925.78 |
DisclosureSEC source: 0001393726-19-000144 · wf-form4_156622920624624.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,997,753 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $6.54 to $6.59, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 11:40 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 6,151 | $6.56 | $40,350.56 |
DisclosureSEC source: 0001393726-19-000144 · wf-form4_156622920624624.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,991,821 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.55 to $6.57, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 14, 2019 Filed Aug 15, 2019 10:05 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 7,887 | $6.54 | $51,580.98 |
DisclosureSEC source: 0001393726-19-000142 · wf-form4_156587790912292.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,985,670 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.51 to $6.57, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 10:05 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 95 | $6.50 | $617.50 |
DisclosureSEC source: 0001393726-19-000142 · wf-form4_156587790912292.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,977,783 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 12, 2019 Filed Aug 13, 2019 09:59 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 3,470 | $6.51 | $22,582.76 |
DisclosureSEC source: 0001393726-19-000140 · wf-form4_156570473366818.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,977,688 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. F3 · shares: This purchase was executed in multiple purchases at prices ranging from $6.48 to $6.55, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 09:59 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 3,648 | $6.53 | $23,803.20 |
DisclosureSEC source: 0001393726-19-000140 · wf-form4_156570473366818.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,974,218 F1 · kind: Pursuant to a Rule 10b5-1 trading plan. F2 · shares: This purchase was executed in multiple purchases at prices ranging from $6.51 to $6.53, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 19:29 UTC |
Goldwasser LesleyDirector
|
GrantCommon Stock | 2,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-19-000128 · wf-form4_156209573322814.xml · nonDerivative · entry 1 Goldwasser Lesley · CIK 0001465575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,710 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 15:34 UTC |
Smith Bradley E.Director
|
GrantCommon Stock | 2,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-19-000134 · wf-form4_156209604208609.xml · nonDerivative · entry 1 Smith Bradley E. · CIK 0001579089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,367 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 15:31 UTC |
Mack John EdwardDirector
|
GrantCommon Stock | 2,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-19-000130 · wf-form4_156209584817750.xml · nonDerivative · entry 1 Mack John Edward · CIK 0001381172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,815 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 15:32 UTC |
Friedman Paul MDirector
|
GrantCommon Stock | 2,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-19-000132 · wf-form4_156209594458170.xml · nonDerivative · entry 1 Friedman Paul M · CIK 0001648181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,370 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 10:41 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 100 | $6.53 | $653.00 |
DisclosureSEC source: 0001393726-19-000126 · wf-form4_156104166631073.xml · nonDerivative · entry 9 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,970,570 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 10:41 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 600 | $6.52 | $3,912.00 |
DisclosureSEC source: 0001393726-19-000126 · wf-form4_156104166631073.xml · nonDerivative · entry 8 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,970,470 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 10:41 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 100 | $6.50 | $650.00 |
DisclosureSEC source: 0001393726-19-000126 · wf-form4_156104166631073.xml · nonDerivative · entry 7 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,969,870 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 10:41 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,000 | $6.48 | $6,480.00 |
DisclosureSEC source: 0001393726-19-000126 · wf-form4_156104166631073.xml · nonDerivative · entry 6 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,969,770 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 10:41 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 100 | $6.47 | $647.00 |
DisclosureSEC source: 0001393726-19-000126 · wf-form4_156104166631073.xml · nonDerivative · entry 5 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,968,770 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 10:41 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 300 | $6.46 | $1,938.00 |
DisclosureSEC source: 0001393726-19-000126 · wf-form4_156104166631073.xml · nonDerivative · entry 4 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,968,670 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 10:41 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 400 | $6.45 | $2,580.00 |
DisclosureSEC source: 0001393726-19-000126 · wf-form4_156104166631073.xml · nonDerivative · entry 3 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,968,370 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 10:41 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 997 | $6.44 | $6,420.68 |
DisclosureSEC source: 0001393726-19-000126 · wf-form4_156104166631073.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,967,970 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 10:41 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 103 | $6.41 | $660.23 |
DisclosureSEC source: 0001393726-19-000126 · wf-form4_156104166631073.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,966,973 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 18, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 3,192 | $6.52 | $20,811.84 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 16 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,966,870 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 18, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 508 | $6.51 | $3,307.08 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 15 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,963,678 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 18, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 500 | $6.50 | $3,250.00 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 14 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,963,170 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 18, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,389 | $6.49 | $9,014.61 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 13 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,962,670 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 18, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 511 | $6.48 | $3,311.28 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 12 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,961,281 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 8,531 | $6.53 | $55,707.43 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 11 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,960,770 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 550 | $6.50 | $3,575.00 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 10 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,952,239 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 100 | $6.49 | $649.00 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 9 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,951,689 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 100 | $6.47 | $647.00 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 8 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,951,589 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 100 | $6.46 | $646.00 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 7 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,951,489 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 101 | $6.45 | $651.45 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 6 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,951,389 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 831 | $6.44 | $5,351.64 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 5 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,951,288 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 600 | $6.43 | $3,858.00 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 4 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,950,457 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 335 | $6.39 | $2,140.65 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 3 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,949,857 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 400 | $6.38 | $2,552.00 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,949,522 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 17, 2019 Filed Jun 19, 2019 10:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 296 | $6.37 | $1,885.52 |
DisclosureSEC source: 0001393726-19-000124 · wf-form4_156095447016875.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,949,122 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 11:29 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 4,179 | $6.40 | $26,745.60 |
DisclosureSEC source: 0001393726-19-000122 · wf-form4_156078534960503.xml · nonDerivative · entry 9 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,948,826 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 11:29 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,621 | $6.39 | $16,748.19 |
DisclosureSEC source: 0001393726-19-000122 · wf-form4_156078534960503.xml · nonDerivative · entry 8 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,944,647 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 11:29 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,440 | $6.38 | $9,187.20 |
DisclosureSEC source: 0001393726-19-000122 · wf-form4_156078534960503.xml · nonDerivative · entry 7 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,942,026 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 11:29 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 907 | $6.37 | $5,777.59 |
DisclosureSEC source: 0001393726-19-000122 · wf-form4_156078534960503.xml · nonDerivative · entry 6 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,940,586 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 11:29 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 558 | $6.35 | $3,543.30 |
DisclosureSEC source: 0001393726-19-000122 · wf-form4_156078534960503.xml · nonDerivative · entry 5 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,939,679 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 11:29 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 340 | $6.32 | $2,148.80 |
DisclosureSEC source: 0001393726-19-000122 · wf-form4_156078534960503.xml · nonDerivative · entry 4 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,939,121 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 11:29 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 100 | $6.32 | $632.00 |
DisclosureSEC source: 0001393726-19-000122 · wf-form4_156078534960503.xml · nonDerivative · entry 3 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,938,781 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 11:29 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,288 | $6.31 | $8,127.28 |
DisclosureSEC source: 0001393726-19-000122 · wf-form4_156078534960503.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,938,681 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 11:29 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 100 | $6.30 | $630.00 |
DisclosureSEC source: 0001393726-19-000122 · wf-form4_156078534960503.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,937,393 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 11:17 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,397 | $6.26 | $8,745.22 |
DisclosureSEC source: 0001393726-19-000120 · wf-form4_156043903043565.xml · nonDerivative · entry 3 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,937,293 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 11:17 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,391 | $6.25 | $8,693.75 |
DisclosureSEC source: 0001393726-19-000120 · wf-form4_156043903043565.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,935,896 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 11:17 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,254 | $6.24 | $7,824.96 |
DisclosureSEC source: 0001393726-19-000120 · wf-form4_156043903043565.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,934,505 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 11, 2019 Filed Jun 12, 2019 10:02 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 300 | $6.26 | $1,878.00 |
DisclosureSEC source: 0001393726-19-000118 · wf-form4_156034816070217.xml · nonDerivative · entry 13 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,933,251 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 11, 2019 Filed Jun 12, 2019 10:02 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,133 | $6.24 | $7,069.92 |
DisclosureSEC source: 0001393726-19-000118 · wf-form4_156034816070217.xml · nonDerivative · entry 12 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,932,951 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.